Skip to main content
Log in

Ventricular repolarization time indexes following anthracycline treatment

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

The anthracyclines, doxorubicin and daunorubicin, are antibiotics effective in the treatment of many malignancies. However, their usefulness is limited by the development of potentially fatal cardiotoxicity. Cardiac monitoring by a nonivasive test capable of identifying patients at high risk of cardiac damage, before the ejection fraction deteriorates would have clinical utility. Electrocardiograms and echocardiograms are routinely utilized for noninvasive assessment of myocardial function. However, of the ECG abnormalities described, none has been noted to be of consistent predictive value for cardiotoxicity. The aim of this study was to assess the effects of doxorubicin on ventricular repolarization time indexes, as they have been shown to be effective in the identification of electrical myocardial instability and, hence, in the identification of risk for either arrhythmia or heart failure. For this reason, electrocardiograms were compared in 35 cancer patients at the first presentation (drug-free state) and after 29.4±37.65 weeks of treatment with doxorubicin. The results of the present study showed that after only a short period of treatment with doxorubicin there was a significant increase in ventricular recovery time dispersion indexes (QTc, JT, and JTc dispersion, and their “adjusted” values). Thus, increased regional variation in ventricular repolarization could be, in the absence of a significant modification of the echocardiographic parameters, an early marker of an electropathy, due to the early cardiotoxic action of doxorubicin on myocardial cells, eventually leading to heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Muggia FM, Green MD (1991) New anthracycline antitumor antibiotics. CRC Crit Rev Oncol Hematol 11:43–64

    Article  CAS  Google Scholar 

  2. Schwartz RG, McKenzie MB, Alexander J (1987) Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Am J Med 82:1109–1118

    Article  PubMed  CAS  Google Scholar 

  3. Steinherz LJ, Steinherz PG, Tan CTC (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266:1672–1677

    Article  PubMed  CAS  Google Scholar 

  4. Steinherz LJ, Steinherz PG (1991) Delayed cardiac toxicity from anthracycline therapy. Pediatrician 18:49–52

    PubMed  CAS  Google Scholar 

  5. Van Hoff DD, Layard M, Basa P (1979) Risk factors for doxorubicin induced congestive heart failure. Ann Intern Med 91:701–717

    Google Scholar 

  6. Lefrak EA, Pitha J, Resenheim S, Gotlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302–314

    Article  PubMed  CAS  Google Scholar 

  7. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, Sandor G, Benson L, Williams R (1992) Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of Childrens Cancer Study Group. Pediatrics 89:942–949

    PubMed  CAS  Google Scholar 

  8. Tedesco MA, Iarussi D, Ratti G, Gualtieri S, Irace L, Romano A, Guadagno I, Coppolino P, Iacono A (1993) Doxorubicin cardiotoxicity assessed with vectorcardiographic and echocardiographic techniques. J Electrocardiol 26:176

    Article  Google Scholar 

  9. Iarussi D, Auricchio U, Tedesco MA, Iacono A, Casale F, Indolfi P, Giuliani M, Murano A, Cutillo L, Di Tullio MT (1993) Late cardiac effects of anthracycline therapy in children with malignancies: a Doppler echocardiographic study. Med Pediatr Oncol 21:565

    Google Scholar 

  10. Pisacane C, Iarussi D, Buono S, Gualtieri S, Coppolino P, Iacono A (1991) Utilità clinica dell’analisi ecocardiografica bidimensionale quantitativa della cinesi segmentaria del ventricolo sinistro nel monitoraggio dei pazienti neoplastici trattati con antracicline. G Ital Cardiol 21:1259–1267

    PubMed  CAS  Google Scholar 

  11. Schwartz PJ, Wolf S (1978) QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074–1077

    PubMed  CAS  Google Scholar 

  12. Moss AJ, Schwartz PJ (1982) Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. Mod Concepts Cardiovasc Dis 51:85–91

    PubMed  CAS  Google Scholar 

  13. Day CP, McComb JM, Campbell RWF (1990) QT dispersion: an indicator of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342–344

    Article  PubMed  CAS  Google Scholar 

  14. Higham PD, Hilton CJ, Aitcheson JD, Furniss SS, Bourke JP, Campbell RWF (1992) QT dispersion reflect dispersion of ventricular recovery? (abstract). Circulation 86[suppl I]:I-392

    Google Scholar 

  15. Davey PP, Bateman J, Mulligam IP, Forfar C, Barlow C, Hart G (1994) QT interval dispersion in chronic heart failure and left ventricular hypetrophy: relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 71:268–273

    Article  PubMed  CAS  Google Scholar 

  16. Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm AJ, McKenna WJ (1996) QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 17:258–263

    PubMed  CAS  Google Scholar 

  17. Wortman JE, Lucas VS Jr, Schuster E (1979) Sudden death during doxorubicin administration. Cancer 44:1588

    Article  PubMed  CAS  Google Scholar 

  18. Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353–370

    Google Scholar 

  19. Day CP, McComb JM, Matthews J, Campbell RWF (1991) Reduction in QT dispersion by Sotalol following myocardial infarction. Eur Heart J 12:423–427

    PubMed  CAS  Google Scholar 

  20. Zabel M, Portnoy S, Franz MR (1995) Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 25:746–752

    Article  PubMed  CAS  Google Scholar 

  21. LaMonte CS, Yeh SDJ, Straus DJ (1986) Long-term follow-up of cardiac function in patients with Hodgkin’s disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin. Cancer Treat Rep 70:439–444

    PubMed  CAS  Google Scholar 

  22. Goorin AM, Chauvenet AR, Perez-Atayde AR, Cruz J, McKone R, Lipshultz SE (1990) Initial congestive heart failure six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr 116:144–147

    Article  PubMed  CAS  Google Scholar 

  23. Freter CE, Lee TC, Billingham ME, Chak L, Bristow ME (1986) Doxorubicin cardiac toxicity manifesting seven years after treatment. Am J Med 80:483–485

    Article  PubMed  CAS  Google Scholar 

  24. Silber JH, Jakacki RI, Larsen RL, Goldwein JW, Barber G (1993) Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 477–479

  25. Bender KS, Shematek JP, Leventhal BG, Kan JS (1984) QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr 105:442–444

    Article  PubMed  CAS  Google Scholar 

  26. Kemper AJ, Dunlap R, Pietro DA (1983) Thiordazine-induced torsade de pointes: successful therapy with isoproterenol. JAMA 249:2931–2934

    Article  PubMed  CAS  Google Scholar 

  27. Wharton JM, Demopulos PA, Goldschlager N (1987) Torsade de pointes during administration of pentamidine isethionate. Am J Med 83:571–576

    Article  PubMed  CAS  Google Scholar 

  28. Monahan BF, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr (1990) Torsade de pointes occurring in association with terfenadine use. JAMA 264:2788–2790

    Article  PubMed  CAS  Google Scholar 

  29. Rubart M, Pressler M, Pride HP, Zipes DP (1992) Mechanisms of erythromycin-induced long QT syndrome. PACE 15:528

    Google Scholar 

  30. Reinoehl J, Frankovich D, Machado C, Kawasaki R, Baga JJ, Pires LA, Steinman RT, Fromm BS, Lehmann MH (1996) Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J 131:1184–1191

    Article  PubMed  CAS  Google Scholar 

  31. Weintraub RG, Gow RM, Wilkinson JL (1990) The congenital long QT syndromes in childhood. J Am Coll Cardiol 16:674–680

    Article  PubMed  CAS  Google Scholar 

  32. Higham PD, Hilton CJ, Aitcheson JD, Furniss SS, Bourke JP, Campbell RWF (1992) QT dispersion reflect dispersion of ventricular recovery? (abstract). Circulation 86 [suppl I]:I-392

    Google Scholar 

  33. Kuo CS, Munakata K, Reddy CP, Surawicz B (1983) Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation 67:1356–1367

    PubMed  CAS  Google Scholar 

  34. Kuo CS, Reddy CP, Munakata K, Surawicz B (1985) Mechanisms of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J 6 [suppl D]:63–70

    PubMed  Google Scholar 

  35. Ducceschi V, Sarubbi B, Giasi A, Russo B, Lucca P, Santangelo L, Giasi M, Iacono A (1996) Correlation between late potentials duration and QTc dispersion: is there a causal relationship? Int J Cardiol 53:285–290

    Article  PubMed  CAS  Google Scholar 

  36. Sarubbi B, Esposito V, Ducceschi V, Meoli I, Grella E, Santangelo L, Iacono A, Caputi M (1997) Effect of blood gas derangement on Qtc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy? Int J Cardiol 58:287–292

    Article  PubMed  CAS  Google Scholar 

  37. Priori S, Napolitano C, Diehl L, Schwartz PJ (1994) Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89:1681–1689

    PubMed  CAS  Google Scholar 

  38. Zareba W, Moss AJ, Ie Cessie S (1994) Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 74:550–553

    Article  PubMed  CAS  Google Scholar 

  39. Yunus A, Gillis AM, Duff HJ, Wyse G, Mitchell LB (1996) Increased precordial Qtc dispersion predicts ventricular fibrillation during acute myocardial infarction. Am Heart J 131:706–708

    Google Scholar 

  40. Bogun F, Chan K, Harvey M, Goyal R, Castellani M, Niebauer M, Daoud E, Man KC, Strickberger A, Morady F, (1996) QT dispersion in nonsustained ventricular tachycardia and coronary artery disease. Am J Cardiol 77:256–259

    Article  PubMed  CAS  Google Scholar 

  41. Binah O, Cohen IS, Rosen MR (1983) The effects of adriamycin on normal and ouabain-toxic canine Purkinje and ventricular muscle fibers. Circ Res 53:655–662

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarubbi, B., Orditura, M., Ducceschi, V. et al. Ventricular repolarization time indexes following anthracycline treatment. Heart Vessels 12, 262–266 (1997). https://doi.org/10.1007/BF02766801

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02766801

Key words

Navigation